Dyspepsia - Buspiron.

Suspended

• Registration Number: NL-OMON20895

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

Healthy volunteers: absence of gastrointestinal symptoms, Nepean Dyspepsia Index (NDI) score < 5, > 18 years of age.

Patients: Nepean Dyspepsia Index (NDI) score >25, > 18 years of age.

Exclusion Criteria

Healthy volunteers: use of drugs that affect gastrointestinal motility (antidepressants, opiates, NSAID’s, calcium-blockers, nitrates), previous abdominal surgery, epilepsy, severe liver of renal insufficience, depression, claustrophobia, metal
implants, not be able to lie down for 15 minutes.

Patients: use of drugs that affect gastrointestinal motility (antidepressants, opiates, NSAID’s, calcium-blockers, nitrates), IBS, previous abdominal surgery, epilepsy, severe liver of renal insufficience, depression, claustrophobia, metal
implants, not be able to lie down for 15 minutes.

Study & Design

• Study Type: Interventional
• Study Design: Not specified